Taiho Ventures
About Taiho Ventures
Taiho Ventures, LLC is an investment firm focused on funding global biotech ventures in alignment with Taiho Pharmaceutical Co., Ltd.’s growth strategy. The company aims to create significant value by supporting innovative science within the biotechnology and pharmaceutical ecosystem and fostering collaborations with Taiho’s corporate network. It emphasizes investments that advance therapeutics and drug development through partnerships and strategic affiliations. Based in the United States, Taiho Ventures coordinates with international biotech startups and companies seeking to accelerate translational science and clinical value for Taiho Oncology and related ventures.
Recent News
Storm Therapeutics Secures $56M to Advance Cancer Drugs
Signadori Bio Raises €11M to Advance Tumour Platform
Storm Therapeutics Secures $56 Million Series C to Push METTL3 Cancer Drug Into Phase 2
STORM Therapeutics Raises €47.5 Million Series C to Harness the Power of RNA Modification to Treat Cancer
Cambridge Biotech STORM Therapeutics Raises $56M